Consumer Defensive
Kobayashi Pharmaceutical Co., Ltd.(KBYPF)
Live Price
Offline$34.05
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 โ Jun 18, 2026
- Market Cap
- $431.69B
- Revenue Growth
- +0.2%
- EPS Growth
- -64.1%
- Dividend Yield
- 1.8%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars ยท May 29, 2026 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Kobayashi Pharmaceutical Co., Ltd. (KBYPF) is a Consumer Defensive stock with a market cap of $431.69B and listed on OTC. The stock last traded around $34.05 and up 0.0% across the available one-year price window (May 29, 2026 โ Jun 18, 2026). Baseline metrics include revenue growth of +0.2%, EPS growth of -64.1%, a dividend yield of 1.8%. What stands out right now is revenue +0.2%, EPS -64.1%, free cash flow +180.3% with operating margin 9.0% and ROIC 6.8%. The dividend is present but secondary, with a yield around 1.8%. Valuation already assumes a fairly strong business story at P/E 118.1 and price/sales 2.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines KBYPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+0.2% vs +1.7% peer median
Operating Margin
Above sector median
+9.0% vs +6.6% peer median
P/E
Above sector median
118.1 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 8, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +0.2% and EPS is at -64.1%, with operating margin around 9.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.8%, which matters if the thesis depends on income as much as growth.
Benchmark Edge
KBYPF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KBYPF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KBYPF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for KBYPF and SPY.
Company Overview
Kobayashi Pharmaceutical Co., Ltd.
Other OTC
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
- Leadership
- Yumi Nakagawa
- IPO Date
- Sep 14, 2015
- Employees
- 3.6k
- Street Address
- KDX Kobayashi Doshomachi Building
- Mailing
- Osaka, 541-0045
- Region
- Osaka, JP
- Reporting Currency
- USD
- Investor Line
- 81 6 6222 0142
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 118.1
- EV/EBITDA
- 30.5
- Price/Sales
- 2.6
- Price/Book
- 2.0
Growth
- Revenue
- +0.2%
- EPS
- -64.1%
- Free Cash Flow
- +180.3%
Profitability
- Gross Margin
- 51.1%
- Operating Margin
- 9.0%
- Net Margin
- 2.2%
- ROE
- 1.7%
- ROIC
- 6.8%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 2.47
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.